Health Catalyst: Achieving FY28 Long-Term Guidance Is Possible [Seeking Alpha]
Health Catalyst, Inc - Common stock (HCAT)
Last health catalyst, inc - common stock earnings: 2/27 04:05 pm
Check Earnings Report
Company Research
Source: Seeking Alpha
The drop in HCAT's share price presents a buying opportunity, as the company's growth initiatives, such as its TEMS offering and next-gen data platform, are expected to drive growth and margin expansion. HCAT's long-term guidance of exceeding $100 million in EBITDA by FY28 is achievable, and its valuation should improve as it demonstrates execution and margin expansion. Investment action I recommended a buy rating for Health Catalyst ( NASDAQ: HCAT ) when I wrote about it the last time (14 Nov 2023), as I expected, HCAT to come out as a stronger business with a better profitability profile as management executes on their growth strategies. Based on my current outlook and analysis of HCAT, I recommend a buy rating. I am confident that HCAT can meet management's FY28 guidance, generating $100 million in EBITDA. As HCAT shows evidence of achieving that over the years (e.g., expanding margins), valuation should start to rerate upwards to peers' levels. Review HCAT reported 4Q23
Show less
Read more
Impact Snapshot
Event Time:
HCAT
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
HCAT alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
HCAT alerts
High impacting Health Catalyst, Inc - Common stock news events
Weekly update
A roundup of the hottest topics
HCAT
News
- Health Catalyst to Announce First Quarter 2024 Operating Results and Host Conference Call on Thursday, May 9, 2024 [Yahoo! Finance]Yahoo! Finance
- Health Catalyst to Announce First Quarter 2024 Operating Results and Host Conference Call on Thursday, May 9, 2024GlobeNewswire
- HROW, HCAT and EGRX are among after hour movers [Seeking Alpha]Seeking Alpha
- Health Catalyst, Inc. (NASDAQ: HCAT) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $16.00 price target on the stock.MarketBeat
- Health Catalyst, Inc. (NASDAQ: HCAT) had its "sector weight" rating re-affirmed by analysts at KeyCorp.MarketBeat
HCAT
Earnings
- 2/22/24 - Beat
HCAT
Sec Filings
- 4/23/24 - Form 10-K/A
- 4/17/24 - Form 4
- 4/15/24 - Form 144
- HCAT's page on the SEC website